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Figure 1: APOBEC3 expression increases during early NSCLC evolution
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Figure 2: APOBEC3 expression increases during either 
replication stress-associated senescence or proliferation 
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Figure 3: APBOEC3B contributes to the accumulation of under-replicated DNA
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LUSC progression dataset (GSE33479) Correlation of CIN70 GSEA score with APOBEC3 expression
































Comparison of matched regions with 
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